Tilray Brands (TLRY) Projected to Post Earnings on Monday

Tilray Brands (NASDAQ:TLRY - Get Free Report) is projected to issue its Q4 2025 quarterly earnings data after the market closes on Monday, July 28th. Analysts expect Tilray Brands to post earnings of ($0.03) per share and revenue of $250.41 million for the quarter.

Tilray Brands Stock Performance

TLRY stock traded down $0.03 on Thursday, reaching $0.70. The company's stock had a trading volume of 30,682,019 shares, compared to its average volume of 42,169,120. Tilray Brands has a 52 week low of $0.35 and a 52 week high of $2.15. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.62 and a quick ratio of 1.61. The company has a market capitalization of $707.37 million, a P/E ratio of -0.67 and a beta of 1.82. The firm has a fifty day moving average of $0.49 and a two-hundred day moving average of $0.66.

Institutional Investors Weigh In On Tilray Brands

A hedge fund recently raised its stake in Tilray Brands stock. AQR Capital Management LLC increased its holdings in Tilray Brands, Inc. (NASDAQ:TLRY - Free Report) by 1,839.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 607,054 shares of the company's stock after purchasing an additional 575,757 shares during the quarter. AQR Capital Management LLC owned 0.06% of Tilray Brands worth $399,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 9.35% of the company's stock.

Analyst Ratings Changes

TLRY has been the topic of a number of recent analyst reports. Wall Street Zen cut shares of Tilray Brands to a "strong sell" rating in a research note on Saturday, July 5th. Piper Sandler dropped their price target on shares of Tilray Brands from $2.00 to $1.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 9th. Finally, Roth Capital reaffirmed a "neutral" rating on shares of Tilray Brands in a research note on Monday, April 14th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $1.92.

Tilray Brands Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.